¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sickle flap"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® flap ÇÑ±Û ÇÇÆÇ, ÇÇºÎÆÇ, ÆÇ
¼³¸í   
  ÇÇÇÏÁ¶Á÷ÀÇ °ËÁøÀ̳ª »óó¹ÞÀº ºÎÀ§¸¦ º¸È£Çϰí, À̽ÄÀ» À§ÇØ ÇÇÇϱ¸Á¶¿¡¼­ ¿Ü°úÀûÀ¸·Î ºÐ¸®µÈ ÇǺγª ´Ù¸¥ Á¶Á÷ÀÇ Ãþ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sickle cell
    ³´ÀûÇ÷±¸
  • sickle cell anemia
    ³´ÀûÇ÷±¸ºóÇ÷, °â»óÀûÇ÷±¸ºóÇ÷
  • sickle cell disease
    ³´ÀûÇ÷±¸º´
  • sickle cell retinopathy
    ³´ÀûÇ÷±¸¸Á¸·º´(Áõ)
  • sickle cell trait
    ³´ÀûÇ÷±¸¼ÒÁú, ³´¼¼Æ÷¼ºÇâ
  • angle-rotation flap
    °¢µ¹¸²ÇÇÆÇ
  • apron flap
    ¾ÕÄ¡¸¶ÇÇÆÇ
  • arm flap
    À§ÆÈÇÇÆÇ
  • arterial flap
    µ¿¸ÆÇÇÆÇ
  • arterial skin flap
    µ¿¸ÆÇÇºÎÆÇ
  • axial flap
    ÃàÇÇÆÇ
  • acromiocervical flap
    ºÀ¿ì¸®¸ñÇÇÆÇ, °ßºÀ°æÇÇÆÇ
  • advancement flap
    ¾Õ¿Å±èÇÇÆÇ, ÀüÁøÇÇÆÇ
  • advancement-rotation flap
    ¾Õ¿Å±èµ¹¸²ÇÇÆÇ, ÀüÁøÈ¸ÀüÇÇÆÇ
  • bilobed neck-shoulder flap
    µÎ¿±¸ñ¾î±úÇÇÆÇ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sickle cell anemia
    ³´ÀûÇ÷±¸ºóÇ÷
  • sickle cell trait
    ³´¼¼Æ÷¼ÒÁú, ³´ÀûÇ÷±¸Çü¼º¼ÒÁú
  • flap
    ÇÇÆÇ, ÇÇºÎÆÇ, ÆÇ
  • advancement flap
    ¾Õ¿Å±èÇÇÆÇ, ÀüÁøÇÇÆÇ
  • muscle flap
    ±ÙÀ°ÆÇ, ±ÙÆÇ
  • pectoralis major myocutaneous flap
    Å«°¡½¿±ÙÇÇÆÇ, ´ëÈä±ÙÇÇÆÇ
  • random flap
    ÀÓÀÇÇÇÆÇ
  • rectus abdominis flap
    ¹è°ðÀº±ÙÆÇ, º¹Á÷±ÙÆÇ
  • regional flap
    ±¹¼ÒÇÇÆÇ
  • rotation flap
    ȸÀüÇÇÆÇ
  • scapular flap
    ¾î±úÇÇÆÇ, °ß°©ÇÇÆÇ
  • skin flap
    ÇÇºÎÆÇ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sickle cell anemia
    ³´ÀûÇ÷±¸ºóÇ÷
  • sickle cell
    ³´ÀûÇ÷±¸
  • sickle cell disease
    ³´ÀûÇ÷±¸º´, °â»óÀûÇ÷±¸º´
  • sickle cell meniscocyte
    ³´ÀûÇ÷±¸
  • sickle cell anemia meniscocytosis
    ³´ÀûÇ÷±¸ºóÇ÷
  • sickle-cell retinopathy
    ³´ÀûÇ÷±¸¸Á¸·º´Áõ
  • sickle cell trait
    ³´¼¼Æ÷¼ÒÁú, ³´ÀûÇ÷±¸Çü¼º¼ÒÁú
  • acromiocervical flap
    ºÀ¿ì¸®¸ñÇÇÆÇ, °ßºÀ°æÇÇÆÇ
  • advancement flap
    ¾Õ¿Å±èÇÇÆÇ, ÀüÁøÇÇÆÇ
  • advancement-rotation flap
    ¾Õ¿Å±èµ¹¸²ÇÇÆÇ, ÀüÁøÈ¸ÀüÇÇÆÇ
  • angle-rotation flap
    °¢µ¹¸²ÇÇÆÇ
  • apron flap
    ¾ÕÄ¡¸¶ÇÇÆÇ
  • arm flap
    À§ÆÈÇÇÆÇ
  • arterial flap
    µ¿¸ÆÇÇÆÇ
  • arterial skin flap
    µ¿¸ÆÇÇºÎÆÇ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Seidels sickle scotoma
    ÀÚÀ̵¨³´¸ð¾ç¾ÏÁ¡
  • Abbes flap
    ¾Ðº£ºÎÆÇ.
  • Tenzel semicircular flap
    ÅÙÁ©¹Ý¿øÁ¶Á÷Æí
  • advancementent flap
    ÀüÁøÆÇ(ÀüÁøÆÇ).
  • free flap
    À¯¸®ÇÇÆÇ
  • glabellar flap
    ¹Ì°£(ÇǺÎ)ÆÇ
  • gracilis flap
    ¹Ú±ÙÇÇÆÇ
  • pharyngeal flap
    ÀÎµÎÆÇ
  • platysmal flap
    ±¤°æ±Ù(ÇÇ)ÆÇ
  • postauricular flap
    ÈÄÀ̰³ÆÇ
  • preauricular flap
    À̰³ÀüºÎÇÇÆÇ
  • radial forearm flap
    ¿ä°ñÀü¿ÏÇÇÆÇ
  • random cutaneous flap
    ÀÓÀÇÇÇÆÇ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • autosplenectomy,in sickle cell disease
    °â»ó¼¼Æ÷º´(ÌÇßÒá¬øàÜ»)
  • sickle cell
    °â»óÀûÇ÷±¸(ÌÇßÒîåúìϹ)
  • sickle cell
    °â»ó(Àû)Ç÷±¸(ÌÇßÒîåúìϹ).
  • sickle cell
    °â»ó(Àû)Ç÷±¸(ÌÇßÒîåúìϹ)
  • sickle cell anemia
    °â»óÀûÇ÷±¸¼º ºóÇ÷
  • sickle cell anemia
    °â»óÀûÇ÷±¸ºóÇ÷
  • sickle cell anemia
    °â»ó(Àû)Ç÷±¸¼º ºóÇ÷ (¡­Þ¸úì).
  • sickle cell anemia
    °â»ó(Àû)Ç÷±¸¼º ºóÇ÷ (¡­Þ¸úì)
  • sickle cell disease
    °â»óÀûÇ÷±¸º´
  • sickle cell disease
    °â»ó(Àû)Ç÷±¸º´.
  • sickle cell disease
    °â»ó(Àû)Ç÷±¸º´(¡­)
  • sickle cell trait
    ÀûÇ÷±¸°â»óÇü¼º°æÇâ
  • sickle cell trait
    ÀûÇ÷±¸°â»óÇü¼º°æÇâ(îåúìϹÌÇßÒû¡à÷ÌËú¾).
  • sickle cell trait
    ÀûÇ÷±¸°â»óÇü¼º°æÇâ(îåúìϹÌÇßÒû¡à÷ÌËú¾)
  • sickle cell type
    °â»óÀûÇ÷±¸Çü
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sickle cell
    ³´¼¼Æ÷(á¬øà)
  • sickle cell anemia
    ³´¼¼Æ÷(á¬øà)ºóÇ÷(Þ¸úì)
  • sickle cell disease
    ³´¼¼Æ÷(á¬øà)Áúȯ(òðü´)
  • sickle cell hemoglobin
    ³´¼¼Æ÷(á¬øà)È÷¸ð±Û·Îºó
  • sickle cell trait
    ³´¼¼Æ÷(á¬øà)¼ºÇâ(àõú¾)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sickle-cell anemia
    °â»ó(Àû)Ç÷±¸¼ººóÇ÷
  • bone flap
    °ñÆí
  • flap
    ÇÇºÎÆÇ, ÇÇÆÇ, ÆÇ, Æí, ÇÇºÎÆí
  • intimal flap
    ³»¸·Æí, ³»¸·ÆÇ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FLAP 5-lipoxygenase activating protein
RAM random-access memory; rapid alternating movements; rectus abdominis muscle; rectus abdominis myocuta...
SCD   1) Sickle Cell Disease
  2) Subacute Combined Degeneration
CSCD Center for Sickle Cell Disease
HbS hemoglobin S, sickle-cell hemoglobin
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FLAP 5-Lipoxygenase activating protein
FEN-1 Flap endonuclease 1
IPPSF isolated perfused porcine skin flap
PMMF Pectoralis major myocutaneous flap
PSR Proliferative sickle retinopathy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sickle cell anemia
    °â»ó ÀûÇ÷±¸ ºóÇ÷
    À¯Àü¼ºÀÇ ¿ëÇ÷¼º ºóÇ÷·Î¼­ ÀÌ»ó Ç÷»ö¼ÒÁõÀÇ ÇϳªÀ̸ç ÈæÀο¡°Ô¼­ ÁÖ·Î ³ªÅ¸³ª°í Ç÷¾×¿¡ °â»ó ÀûÇ÷±¸°¡ ÀÖ´Â °ÍÀÌ Æ¯Â¡ÀÌ´Ù.
  • sickle cell trait
    °â»ó ÀûÇ÷±¸ ¼ÒÁú
    »ê¼Ò ºÐ¾ÐÀÌ ³·Àºµ¥¼­ Æø·ÎµÈ ¶§ ÀûÇ÷±¸ÀÇ °â»óÈ­·Î ÀνĵǴ »ç¶÷ÀÇ »óÅÂ. °â»ó ÀûÇ÷±¸ ºóÇ÷°ú °ü°è°¡ ÀÖ´Â ´ë¸³À¯ÀüÀÚÀÇ ÇìÅ×·Î Á¢ÇÕ¿¡ ±âÀÎÇÑ´Ù.
  • sickle-cell anemia
    °â»ó ÀûÇ÷±¸ ºóÇ÷
    À¯ÀüÀûÀ¸·Î Çì¸ð±Û·Îºó º£Å¸ ±Û·Îºó chainÀÌ valineÀ¸·Î ¹Ù²î¾î ³´ ¸ð¾çÀÇ ÀûÇ÷±¸¸¦ »ý¼ºÇÏ´Â »óÅÂ. ÈæÀο¡°Ô¼­ ¸¹ÀÌ ¹ß»ýÇÑ´Ù.
  • sickle-cell trait
    ÀûÇ÷±¸ °â»óÇü¼º °æÇâ
  • bladder flap urethroplasty
    ¹æ±¤ÆÇ ¿äµµ ¼ºÇü¼ú
  • cross leg flap
    ÇÏÅð ±³Â÷ ÇÇÆÇ
  • flap operation
    ÇÇºÎÆÇ ¼ºÇü¼ú
  • intimal flap
    ³»¸·Æí, ³»¸·ÆÇ
  • jump flap
    Á¡ÇÁ ÇÇºÎÆÇ
  • labiobuccal flap
    ¼øÇùÃø ÇǺκ¯
  • lateral repositioned flap operation
    Ä¡Àº Ãø¹æ À̵¿¼ú
  • mucoperiosteal flap
    Á¡¸· °ñ¸·ÆÇ
  • osteoplastic flap
    °ñ ¼ºÇü¼º ÆÇ, °ñ Çü¼º ÆÇ
  • pedicle flap
    À¯°æ ÇÇºÎÆÇ
    µ¿ÀǾî=
  • pharyngeal flap
    ÀεΠÇÇÆÇ, ÀÎµÎÆí
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
sickle flap A sickle-shaped flap from the anterior scalp and one side of the forehead, based on the opposite temporal artery.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
anaemia, sickle cell A disease characterised by chronic haemolytic anaemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for haemoglobin s.
(12 Dec 1998)
haemoglobin, sickle An abnormal haemoglobin resulting from the substitution of valine for glutamic acid at position 6 of the beta chain of the globin moiety. The heterozygous state results in sickle cell trait, the homozygous in sickle cell anaemia.
(12 Dec 1998)
sickle 1. A reaping instrument consisting of a steel blade curved into the form of a hook, and having a handle fitted on a tang. The sickle has one side of the blade notched, so as always to sharpen with a serrated edge. Cf. Reaping hook, under Reap. "When corn has once felt the sickle, it has no more benefit from the sunshine." (Shak)
2. <astronomy> A group of stars in the constellation Leo.
<botany> Sickle pod, a kind of rock cress (Arabis Canadensis) having very long curved pods.
Origin: OE. Sikel, AS. Sicol; akin to D. Sikkel, G. Sichel, OHG. Sihhila, Dan. Segel, segl, L. Secula, fr. Secare to cut; or perhaps from L. Secula. See Saw a cutting instrument.
Source: Websters Dictionary
(01 Mar 1998)
sickle cell <haematology, pathology> An erythrocyte that changes from the normal discoid shape to a sickled shape when the oxygen tension is low.
The pesence of these cells indicates that the patient is homozygotes for the allele that codes for haemoglobin S and that the patient has sickle cell anaemia.
(18 Nov 1997)
sickle cell anaemia <haematology> Disease common in races of people from areas in which malaria is endemic.
The cause is a point mutation in the allele that codes for the beta chain of haemoglobin with a substitution of (valine for glutamic acid at position 6. The defective haemoglobin (HbS) crystallizes readily at low oxygen tension.
In consequence, erythrocytes from homozygotes change from the normal discoid shape to a sickled shape when the oxygen tension is low and these sickled cells become trapped in capillaries or damaged in transit, leading to severe anaemia.
In heterozygotes, the disadvantages of the abnormal haemoglobin are apparently outweighed by increased resistance to Plasmodium falciparum malaria, probably because parasitised cells tend to sickle and are then removed from circulation.
Symptoms include joint pain, acute abdominal pain, and ulcerations of the lower extremities.
Origin: Gr. Haima = blood
(18 Nov 1997)
sickle cell anaemia: bone manifestations <radiology> 8-13% of blacks carry sickling factor, symptoms: chronic ulcers, pain crises, many infections, priapism X-ray findings: deossification due to marrow hyperplasia, decreased bone density in skull with widened diploe, H-shaped vertebrae or fish vertebrae, rib notching, thrombosis and infarction, avascular necrosis, especially femoral head, periosteal treatmentn (bone within bone), secondary osteomyelitis, Staph. Aureus greater than Salmonella, dactylitis = hand foot syndrome, growth effects, bone shortening secondary to diminished blood supply, death less than 40y
(12 Dec 1998)
sickle cell C disease A disease resulting from abnormal sickle-shaped erythrocytes (containing haemoglobin C and S) which appear in response to a lowering of the partial pressure of oxygen; characterised by anaemia, crises due to haemolysis or vascular occlusion, chronic leg ulcers and bone deformities, and infarcts of bone or of the spleen.
(05 Mar 2000)
sickle cell crisis <haematology> Disease common in races of people from areas in which malaria is endemic.
The cause is a point mutation in the allele that codes for the beta chain of haemoglobin with a substitution of (valine for glutamic acid at position 6. The defective haemoglobin (HbS) crystallizes readily at low oxygen tension.
In consequence, erythrocytes from homozygotes change from the normal discoid shape to a sickled shape when the oxygen tension is low and these sickled cells become trapped in capillaries or damaged in transit, leading to severe anaemia.
In heterozygotes, the disadvantages of the abnormal haemoglobin are apparently outweighed by increased resistance to Plasmodium falciparum malaria, probably because parasitised cells tend to sickle and are then removed from circulation.
Symptoms include joint pain, acute abdominal pain, and ulcerations of the lower extremities.
Origin: Gr. Haima = blood
(18 Nov 1997)
sickle cell dactylitis <syndrome> Recurrent painful swelling of the hands and feet occurring in infants and young children with sickle cell anaemia.
Synonym: sickle cell dactylitis.
(05 Mar 2000)
sickle cell disease <haematology> Disease common in races of people from areas in which malaria is endemic.
The cause is a point mutation in the allele that codes for the beta chain of haemoglobin with a substitution of (valine for glutamic acid at position 6. The defective haemoglobin (HbS) crystallizes readily at low oxygen tension.
In consequence, erythrocytes from homozygotes change from the normal discoid shape to a sickled shape when the oxygen tension is low and these sickled cells become trapped in capillaries or damaged in transit, leading to severe anaemia.
In heterozygotes, the disadvantages of the abnormal haemoglobin are apparently outweighed by increased resistance to Plasmodium falciparum malaria, probably because parasitised cells tend to sickle and are then removed from circulation.
Symptoms include joint pain, acute abdominal pain, and ulcerations of the lower extremities.
Origin: Gr. Haima = blood
(18 Nov 1997)
sickle cell haemoglobin <haematology> Haemoglobin S is an abnormal version of the protein haemoglobin.
The sixth amino acid of the normal beta chain, glutamic acid, is replaced by valine with gluconic acid. This mutation causes the red blood cell to take on a sickle shape, and is the cause of the sickle cell trait condition (when the individual is heterozygous for this mutant haemoglobin) and the disease of sickle cell anaemia (when the individual is homozygous for this mutant haemoglobin).
(09 Oct 1997)
sickle cell prep <haematology, investigation> A test which looks at red blood cells under the microscope to detect sickle cells after an agent which lowers the oxygen content of the sample is added.
A positive test is result is determined by the presence of sickle cells. Abnormal results indicate sickle cell anaemia or sickle cell trait.
(27 Sep 1997)
sickle cell retinopathy A condition marked by dilation and tortuosity of retinal veins, and by microaneurysms and retinal haemorrhages; advanced stages may show neovascularization, vitreous haemorrhage, or retinal detachment.
(05 Mar 2000)
sickle cell test <investigation> A test which looks at red blood cells under the microscope to detect sickle cells after an agent which lowers the oxygen content of the sample is added. A positive test is result is determined by the presence of sickle cells. Abnormal results indicate sickle cell anaemia or sickle cell trait.
(27 Sep 1997)
sickle cell-thalassaemia disease Anaemia, clinically resembling sickle cell anaemia, in which individuals are compound heterozygous for the sickle cell gene and a thalassaemia gene; about 60 to 80% of haemoglobin is Hb S, up to 20% Hb F, and the remainder Hb anaemia.
Synonym: sickle cell-thalassaemia disease.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sickle
    ³´
  • hammer and sickle
    (ÇØ¸Ó¿Í ³´À¸·Î µÈ)¼Ò·Ã ±¹±â
  • sickle
    (ÀÛÀº) ³´;~ cell anemia °âÇü ÀûÇ÷±¸ ºó
  • flip-flap
    °øÁßÁ¦ºñ
  • coal-flap
    COAL-CELLARÀÇ ¶Ñ²±
  • flap
    ÆÞ·°°Å¸®´Ù;³¯°³¸¦ ÆÛ´öÀÌ´Ù;Âû½Ï¶§¸®´Ù;Ãà ´Ã¾îÁö(°Ô ÇÏ)´Ù;ÆÞ·°ÀÓ;³¯°³Ä§;Âû½Ï;´Ã¾îÁø °Í;º¸Á¶ÀÍ;ÈïºÐ
  • flap door
    ¾Æ·¡·Î ¿©´Â ¹®
  • landing flap
    Âø·ú Á¶ÀÛ º¸Á¶ÀÍ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á